Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF

Sandra Sanders-van Wijk, Stefano Muzzarelli, Michael Neuhaus, Stephanie Kiencke, Micha Maeder, Werner Estlinbaum, Daniel Tobler, Kurt Mayer, Paul Erne, Matthias E. Pfisterer, Hans-Peter Brunner-La Rocca

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)910-918
JournalEuropean journal of heart failure
Volume15
Issue number8
DOIs
Publication statusPublished - Aug 2013

Keywords

  • Heart failure
  • Natriuretic peptide
  • Safety
  • Drug therapy
  • Ageing
  • Co-morbidities

Cite this

Sanders-van Wijk, S., Muzzarelli, S., Neuhaus, M., Kiencke, S., Maeder, M., Estlinbaum, W., Tobler, D., Mayer, K., Erne, P., Pfisterer, M. E., & Brunner-La Rocca, H-P. (2013). Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF. European journal of heart failure, 15(8), 910-918. https://doi.org/10.1093/eurjhf/hft079